---
title: 'Integrative genomic analyses of European intrahepatic cholangiocarcinoma:
  Novel ROS1 fusion gene and PBX1 as prognostic marker'
date: '2024-06-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38877653/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240616180959&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: By analyzing an additional European cohort of iCCA patients,
  we found that PBX1 protein expression was a marker of poor prognosis. Overall, our
  findings provide insight into key molecular alterations in iCCA, reveal new targetable
  fusion genes, and suggest that PBX1 is a novel modulator of this ...'
disable_comments: true
---
CONCLUSIONS: By analyzing an additional European cohort of iCCA patients, we found that PBX1 protein expression was a marker of poor prognosis. Overall, our findings provide insight into key molecular alterations in iCCA, reveal new targetable fusion genes, and suggest that PBX1 is a novel modulator of this ...